NEU 2.99% $20.10 neuren pharmaceuticals limited

Ann: Prader-Willi syndrome IND for NNZ-2591 approved by FDA, page-4

  1. 182 Posts.
    lightbulb Created with Sketch. 8
    Great news, awesome to see the team at NEU ticking the boxes - next stop ROW and FDA approval!!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.